Drug safety
Monitoring and managing the safety of medicines before and after approval, including adverse-event reporting.
Overview
Monitoring and managing the safety of medicines before and after approval, including adverse-event reporting. It is one of the core compliance areas in its sector, with obligations from statute, regulation, guidance and, often, industry standards.
It connects most directly to Pharmaceuticals.
Check the official sources below for legal scope, applicable dates and exceptions. This entry is an explanatory reference, not legal advice.
Why it matters
Pharmacovigilance failures can harm patients and trigger enforcement.
Who it affects
Organisations in pharmaceuticals and related sectors.
Where it sits
Ten linked steps connect where you operate to the proof that you complied.
- 01Jurisdiction
- 02Industry
- 03Activity
- 04Authority
- 05Regulation
- 06Requirement
- 07Guidance
- 08Control
- 09Evidence
- 10Enforcement
Connections
The terms most closely tied to Drug safety. Select one to open it.
What to do about it
- 1List the laws and authorities in this area that apply to you.
- 2Map each obligation to a control and owner.
- 3Monitor change and enforcement in the area.
- 4Report coverage and gaps to management.
From requirement to evidence.
Regulation Layer maps these obligations to tested controls and sealed evidence, with deadlines on the dial.
Request early access →